We have found transition metals tightly bound to apolipoprotein A-I-containing lipoproteins [Lp(A-I)] isolated by selected affinity immunosorption from human serum. Prominent among the metal ions detected were iron and copper. By immunoblotting the proteins of Lp(A-I), we detected both transferrin and ceruloplasmin. The transferrincontaining Lp(A-I) particles, isolated by selected aflmity immunosorption against transferrin, were larger (mean diameter of 14.2 nm) and had a higher protein content than most high density lipoproteins (HDL). Ultracentrifugally isolated HDL were found to contain much less transferrin, whereas transferrin was found associated with apolipoprotein A-I from the >1.21-g/ml ultracentrifugal fraction. This suggests that the complex is not recovered in the classic HDL density interval because of its very high density. HDL inhibit copper-catalyzed oxidation of low density lipoproteins (LDL) in vitro. We have found that immunoisolated Lp(A-I) are an order of magnitude more effective in inhibiting the oxidation of LDL than ultracentrifugally isolated HDL, on the basis of protein mass. When
High density lipoproteins (HDL) include a number of discrete lipid-protein complexes (1) (2) (3) (4) (5) (6) (7) . They are thought to perform a wide variety of functions (8) (9) (10) (11) (12) (13) (14) (15) in addition to their involvement with cholesterol transport (16) . Diversity in function could be a reflection of the differing protein components residing on individual HDL species.
Loss of apolipoproteins associated with HDL during isolation by sequential ultracentrifugation has been well documented (17) (18) (19) (20) . Other proteins not considered to be integral to HDL but which associate partially with HDL under physiological conditions might also become lost from the HDL density fraction during ultracentrifugation due either to dissociation or by having a particle density outside the HDL density range. Loss of such elements could seriously limit detection of special functions of HDL.
In contrast, isolation of apolipoprotein (apo) A-Icontaining lipoproteins [Lp(A-I)] by selected affinity immunosorption (SAIS) appears to retain apolipoproteins otherwise lost from HDL during sequential ultracentrifugation (21) (22) (23) . Lecithin-cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) remain bound to immunoisolated Lp(A-I) and not to ultracentrifugally isolated HDL (24) .
In this study we found that Lp(A-I) preferentially bind transition metals-in particular, iron and copper. This association appears to be attributable to the presence of Lp(A-I) containing transferrin and ceruloplasmin. We have found that the oxidation of low density lipoproteins (LDL) by copper, in vitro, is inhibited by Lp(A-I) particles containing transferrin or ceruloplasmin.
METHODS
Reagents. We obtained goat antisera against transferrin, ceruloplasmin, and apo A-II from International Immunology (Murrieta, CA). Anti-apo A-I and apo A-I immunodiffusion plates were from Tago. Transferrin, ceruloplasmin, and a2-macroglobulin were from Boehringer Mannheim; cyanogen bromide-activated Sepharose from Pharmacia; a choline assay from Wako (Osaka); protein standard from Pierce; and microwell plates from Costar. Other materials were from Sigma.
Serum Samples. Venous blood was drawn from fasting normolipidemic men and women. The blood was allowed to clot for 1 hr at 40C. The serum was recovered by centrifugation at 1000 x g for 30 min at 40C. Gentamicin sulfate, benzamidine, and phenylmethanesulfonyl fluoride (10 ug/ ml, 0.3 mg/ml, and 10 ,ug/ml, respectively) were added to the serum stored at 40C.
Isolation of Lipoproteins. Lp(A-I) were isolated by SAIS using antibodies against apo A-I, as described (21, 22, 25) . Column buffers containing 5 mM Tris and 0.15 M NaCl (pH 7.4, TBS) or 0.2 M acetic acid and 0.15 M NaCl (pH 3.0) were prepared with deionized, double-distilled water and were devoid of EDTA and sodium azide.
Lp(A-I) containing transferrin were isolated from total Lp(A-I) by a second step of SAIS with antibodies against human transferrin. Ceruloplasmin complexes were removed from Lp(A-I) by a third separate SAIS step. A sham column was prepared, exactly as the immunosorption column against apo A-I, with antibodies isolated from nonimmune goat serum. The eluate from the sham column was compared with that from an anti-apo A-I column run in an identical manner. Transferrin was measured in equal volumes of eluate from the anti-apo A-I and sham columns. LDL (1.019-1.063 g/ml) and HDL (1.063-1.21 g/ml) were isolated by repeated sequential ultracentrifugation (26 (30) , and triacylglycerols by their glycerol content (31) .
Competitive ELISA techniques were developed for measurement of apo A-I and transferrin. Linear responses were obtained for apo A-I between 0.5 and 40 ng and for transferrin between 1.5 and 100 ng.
Diameters of the lipoproteins were determined from electron micrographs by a computer-based method (32) . Particle sizes were confirmed by nondenaturing gradient gel electrophoresis (5) and gel filtration with a Pharmacia Sepharose 12 column. The proteins were analyzed by electrophoresis in 0.1% sodium dodecyl sulfate on a 5-25% polyacrylamide gradient gel (SDS/PAGE) (25) . Gels were stained with Coomassie blue R-250 or immunoblotted on nitrocellulose (33).
Oxidation ofLDL. LDL (10 mg/ml) isolated in the presence of 0.04% EDTA were dialyzed against 150 mM NaCl/40 mM phosphate, pH 7.0/0.01% EDTA and stored at 4°C. The LDL were diluted to a final concentration of 100 ,ug/ml in 150 mM NaCl/40 mM phosphate, pH 7.4/5 ,uM CUSO4. In separate tubes increasing amounts of HDL or Lp(A-I) were added to the LDL. HDL and Lp(A-I) were dialyzed in TBS devoid of EDTA; additions were made such that equal volumes of HDL/dialysate were added to each LDL incubation. As a control, EDTA at a final concentration of 200 ,uM was added to one tube of diluted LDL. The mixtures were incubated for 90 min at 37°C. We found that production of thiobarbituric acid-reactive substances (TBARS) reached a plateau within this time (data not shown). Further incubation caused the density of the LDL to increase to >1.065 g/ml, interfering with the reisolation of the LDL. Oxidation was terminated with EDTA and butylated hydroxytoluene added to final concentrations of 200 AuM and 50 ,uM, respectively. The LDL were analyzed directly or after isolation by ultracentrifugation of the incubation mixture at a density of 1.065 g/ml.
LDL oxidation was measured by the production ofTBARS (34). We obtained similar results whether we measured TBARS directly from the incubate or after LDL recovery. Seven of eight HDL samples did not appear to generate significant TBARS within 90 min. The unmodified free amino (19 32) and aluminum (141 179) were also detected.
To determine whether the binding of transition metals to HDL was due to specific binding proteins, we analyzed Lp(A-I) and identified a subfraction that contained tightly bound transferrin by immunoblotting proteins separated by SDS/PAGE (Fig. 1) . The transferrin contents of three Lp(A-I) samples were found to be 0.15 ± 0.01% of plasma transferrin (Table 1) .
In contrast to Lp(A-I), the eluate from a sham column contained only trace amounts of transferrin (Fig. 1) . Transferrin was found associated with ultracentrifugally isolated HDL but at a very low level (Fig. 2) . Transferrin was demonstrable by immunoblotting when we examined the apo A-I-containing particles isolated by immunosorption from the >1.21-g/ml density fraction of human serum (data not shown).
Transferrin-containing Lp(A-I) were isolated by SAIS using affinity-purified antibodies against human transferrin. The particles obtained were distinctly larger than the bulk of Lp(A-I) (14.2 + 2.3-nm mean diameter; Fig. 3 ). The size was confirmed by gel filtration chromatography and by nondenaturing gradient gel electrophoresis (data not shown). In electron micrographs, the particles do not appear to possess translucent lipid-rich cores. They contain 89% protein, 9% phospholipid, and minute amounts of nonpolar lipid (Table  2) . Transferrin and apo A-I were the major proteins. No apo A-II was detected on immunoblots (Fig. 4) .
Lp(A-I) were also found to contain ceruloplasmin by immunoblotting (data not shown). Only trace amounts of ceruloplasmin were detected in the eluate from the sham column, and the amount of ceruloplasmin in ultracentrifu- about 2-fold in these subjects. Copper and iron were associated with ultracentrifugally isolated HDL from subjects 1 and 2, but their concentrations were dramatically reduced. After removal of transferrin-and ceruloplasmin-containing complexes from Lp(A-I) of subjects 1 and 2, iron and copper were no longer detectable, suggesting that their presence in HDL was attributable to the transferrin and ceruloplasmin complexes (Table 3) .
HDL can inhibit Cu2+-catalyzed oxidation of LDL in vitro (37, 38) . Immunoisolated Lp(A-I) were almost an order of magnitude more effective at inhibiting the production of TBARS in LDL than an equal mass of ultracentrifugally isolated HDL from the same individual (Fig. 5) . Lp(A-I) also appeared to protect the free amino groups of apo B, as determined by reactivity with trinitrobenzenesulfonic acid (Fig. 6) , and to inhibit the degradation of apo B-100 (data not shown). Removal of transferrin-and ceruloplasmin-containing lipoproteins from Lp(A-I) reduced the ability of the remaining Lp(A-I) to inhibit the oxidation of LDL by almost one-half (Fig. 7) . In preliminary experiments, we could inhibit the oxidation of LDL with transferrin or ceruloplasmin alone, but only at concentrations that were =2 orders of magnitude higher than were present in Lp(A-I) that produced the same degree of inhibition (data not shown).
DISCUSSION
We found that transition metals bind to Lp(A-I). These metal ions are all known ligands of transferrin or ceruloplasmin. The subpopulations of Lp(A-I) that bind these ions appear to contain transferrin and ceruloplasmin and to inhibit the oxidation of LDL, in vitro. Isolation of Lp(A-I) by selected affinity immunosorption yields lipoprotein particles that retain more proteins than do lipoproteins isolated by sequential ultracentrifugation (21) (22) (23) ). An increased content of apo A-IV (39), CETP (24) , and LCAT (24) has been reported when HDL were isolated by minimally perturbing methods. In addition, previously undocumented proteins have been coisolated with Lp(A-I) obtained by immunoaffinity chromatography. James et al. (40) have detected at least six unidentified protein spots by two-dimensional gel electrophoresis of Lp(A-I) proteins. By transblotting of two-dimensional gels and sequence analysis, we have identified a number of plasma proteins in association with Lp(A-I) (41) . As with these selected plasma proteins, transferrin appears to have significant affinity for Lp(A-I).
Three observations indicate that the association of transferrin with Lp(A-I) is not artifactual. (i) Transferrin is also detectable in HDL isolated by ultracentrifugation, an independent method ofisolation. Additionally, we detected trans- ferrin-apo A-I complexes in the >1.21-g/ml centrifugal fraction.
(ii) The failure to recover significant quantities of transferrin from sham columns indicates that transferrin is not directly bound to the anti-apo A-I columns. (iii) Immunosorption columns prepared with antibody against transferrin also retain apo A-I, implying that the two proteins reside on the same complex. Oxidation of LDL is thought to be a key element in the atherosclerotic process (42) . HDL can inhibit the Cu2+-catalyzed oxidation of LDL in vitro (37, 38) . We have found that Lp(A-I) are more effective in the inhibition of LDL oxidation than ultracentrifugally isolated HDL and that a significant part of this in vitro inhibition can be attributed to the quantitatively minor subfractions of transferrin-and ceruloplasmin-containing Lp(A-I). Ohta et al. (38) have found that particles with apo A-I but without apo A-II possess a greater inhibitory capacity than particles containing both apo A-I and apo A-II. Our finding that apo A-II cannot be detected in transferrin-containing Lp(A-I) particles is consistent with this finding. Klimov et al. (43) suggested that LCAT is capable of inhibiting the oxidation of LDL (43) . Perhaps the LCAT-containing Lp(A-I) along with the metalbinding Lp(A-I) can account for the inhibition of the oxidation of LDL that we observe with immunoisolated Lp(A-I) in vitro.
Parthasarathy et al. (44) have found that HDL do not block the ultimate oxidation of LDL in a 24-hr incubation; however, the HDL did appear to block the uptake ofthe oxidized LDL by macrophages. This finding, coupled with the previously stated results, suggests that HDL may have two effects upon LDL oxidation.
The importance of this in vitro phenomenon to the oxidation of LDL in vivo is unknown. Non-HDL-associated transferrin is present in much greater abundance in plasma than in HDL. Even though transferrin alone has been shown to inhibit the oxidation of LDL (45), it appears that the levels of transferrin and ceruloplasmin needed to inhibit the oxidation of LDL are -2 orders of magnitude more than that complexed with Lp(A-I). Also, we found that adding Lp(A-I) to the incubation mixture did not significantly change the bulk concentration of free copper (data not shown). Perhaps transferrin-containing Lp(A-I) may function by interacting in some specific way with the substrate LDL. Transferrin is a potent inhibitor of transition metal-catalyzed reactions, which lead to the formation of free radicals in biological Proc. Natl. Acad. Sci. USA 89 (1992) 6997 systems. The coupling of transferrin with a lipoprotein may thus allow the localization of this metal-sequestering activity in selected tissue sites. The existence of a parallel lipoprotein complex containing ceruloplasmin may reflect coupled activity between ceruloplasmin and transferrin. The ferroxidase activity of ceruloplasmin allows the oxidation of Fe(II) to Fe(III) without the production of oxygen radicals and has been shown to inhibit iron-mediated oxidation of fatty acids.
Even though the subfraction of Lp(A-I) containing transferrin is small compared with plasma levels of either transferrin or apo A-I, it may nevertheless have significance in lipoprotein metabolism. The interaction between transferrin and the transferrin receptor has been well documented (46) . It is thus possible that the transferrin receptors may provide a pathway for the endocytosis of at least one subfraction of HDL. In addition, transferrin has been reported to stimulate cell replication. Perhaps the presence of transferrin on HDL might explain the stimulation of replication of endothelial cells, which has been described with HDL (8) . In any case, the association of metal-binding proteins with lipoproteins may confer special biochemical properties on the complex with respect to localization ofthese functions at specific sites.
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